LakeShore Biopharma Co., Ltd
LSB · NASDAQ
3/31/2025 | 9/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $28 | $49 | $246 | $223 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $502 | $530 | $444 | $403 |
| Inventory | $228 | $199 | $205 | $191 |
| Other Curr. Assets | $85 | $75 | $8 | $10 |
| Total Curr. Assets | $842 | $852 | $903 | $827 |
| Property Plant & Equip (Net) | $414 | $450 | $481 | $569 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $73 | $68 | $71 | $73 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $28 | $22 | $0 | $10 |
| Other NC Assets | $10 | $40 | $58 | $32 |
| Total NC Assets | $525 | $580 | $610 | $684 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,368 | $1,433 | $1,513 | $1,511 |
| Liabilities | – | – | – | – |
| Payables | $50 | $47 | $68 | $11 |
| Short-Term Debt | $391 | $290 | $324 | $429 |
| Tax Payable | $3 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $2 | $0 | $392 |
| Other Curr. Liab. | $380 | $392 | $411 | $52 |
| Total Curr. Liab. | $825 | $730 | $802 | $883 |
| LT Debt | $24 | $79 | $101 | $126 |
| Deferred Rev, NC | $16 | $17 | $20 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $4 | $5 | $6 |
| Total NC Liab. | $43 | $100 | $126 | $131 |
| Other Liabilities | $0 | $0 | $0 | $21 |
| Cap. Leases | $0 | $2 | $7 | $6 |
| Total Liabilities | $868 | $830 | $928 | $1,036 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,407 | -$2,287 | -$2,308 | -$2,127 |
| AOCI | -$57 | -$63 | -$58 | -$56 |
| Other Equity | $2,964 | $2,953 | $2,951 | $2,657 |
| Total Equity | $500 | $603 | $585 | $475 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,368 | $1,433 | $1,513 | $1,511 |
| Net Debt | $386 | $319 | $178 | $332 |